HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Samer Mansour Selected Research

Samer Mansour Research Topics

Disease

14Myocardial Infarction
12/2021 - 04/2006
12ST Elevation Myocardial Infarction
09/2021 - 10/2010
7Infarction (Infarctions)
11/2020 - 08/2005
5COVID-19
01/2022 - 01/2020
5Hemorrhage
01/2022 - 08/2005
5Stroke (Strokes)
12/2021 - 12/2016
5Cardiomyopathies (Cardiomyopathy)
10/2017 - 04/2013
4Thrombosis (Thrombus)
01/2022 - 11/2020
4Ischemia
01/2022 - 11/2012
4Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 11/2016
4Coronary Artery Disease (Coronary Atherosclerosis)
11/2019 - 08/2013
3Atrial Fibrillation
12/2021 - 03/2020
3Heart Failure
01/2018 - 04/2010
2Hyperplasia
01/2022 - 01/2016
2Acute Coronary Syndrome
12/2021 - 10/2017
2Left Ventricular Dysfunction
11/2020 - 01/2011
2Death (Near-Death Experience)
11/2020 - 11/2016
2Hypoxia (Hypoxemia)
01/2020 - 11/2012
2Myocardial Ischemia (Ischemic Heart Diseases)
11/2014 - 10/2010
1Vascular System Injuries
01/2022
1Diabetes Mellitus
01/2022
1Transient Ischemic Attack
12/2021
1Coronary Disease (Coronary Heart Disease)
12/2021
1Cytokine Release Syndrome
01/2020
1Respiratory Insufficiency (Respiratory Failure)
01/2020
1Virus Diseases (Viral Diseases)
01/2020
1Peripheral Arterial Disease
11/2017
1Paraganglioma (Paragangliomas)
10/2017
1Pheochromocytoma
10/2017
1Takotsubo Cardiomyopathy
10/2017
1Pathologic Constriction (Stenosis)
11/2016
1AIDS-Related Complex (ARC)
01/2016
1Inflammation (Inflammations)
11/2012
1Intraoperative Complications
08/2005

Drug/Important Bio-Agent (IBA)

3EverolimusFDA Link
11/2019 - 11/2016
3dimemorfan (AT 17)IBA
11/2018 - 10/2010
2CalciumIBA
01/2021 - 01/2018
2CobaltIBA
11/2019 - 12/2016
2ChromiumIBA
11/2019 - 12/2016
2Fluorocarbon PolymersIBA
11/2019 - 12/2016
2omega-Chloroacetophenone (Mace)IBA
10/2017 - 11/2016
2Paclitaxel (Taxol)FDA LinkGeneric
10/2017 - 11/2016
2Phenobarbital (Luminal)FDA Link
01/2007 - 04/2006
1Alendronate (Alendronate Sodium)FDA LinkGeneric
01/2022
1VaccinesIBA
01/2022
1insulin receptor-related receptor (IRR)IBA
09/2021
1SolutionsIBA
06/2021
1AntithrombinsIBA
11/2020
1Adrenergic Agents (Adrenergic Drugs)IBA
01/2020
1celastrolIBA
06/2019
1Mitochondrial Permeability Transition PoreIBA
06/2019
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2018
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
01/2018
1TicagrelorIBA
01/2018
1Dihydrotachysterol (AT 10)IBA
01/2018
1Pharmaceutical PreparationsIBA
10/2017
1CatecholaminesIBA
10/2017
13-Iodobenzylguanidine (Iobenguane)IBA
10/2017
1Cytidine Monophosphate (CMP)IBA
11/2014
1TransferasesIBA
11/2012
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
11/2012
1Glycoproteins (Glycoprotein)IBA
12/2011
1Enoxaparin (Lovenox)FDA LinkGeneric
10/2010
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
10/2010
1Heparin (Liquaemin)FDA LinkGeneric
10/2010
1Glucose (Dextrose)FDA LinkGeneric
08/2005

Therapy/Procedure

14Stents
01/2022 - 08/2005
13Therapeutics
12/2021 - 04/2010
12Percutaneous Coronary Intervention
01/2022 - 12/2011
9Coronary Artery Bypass (Coronary Artery Bypass Surgery)
11/2020 - 01/2011
4Drug-Eluting Stents
11/2019 - 11/2016
2Perioperative Period
01/2022 - 10/2013
2Critical Care (Surgical Intensive Care)
01/2022 - 01/2021
2Treatment Delay
06/2021 - 01/2017
2Injections
04/2013 - 01/2011
2Cell- and Tissue-Based Therapy (Cell Therapy)
11/2012 - 10/2010
2Transplantation
11/2012 - 10/2010
1Vascular Surgical Procedures
01/2022
1Secondary Prevention
10/2021
1Ambulatory Care (Outpatient Care)
01/2020
1Cardiac Rehabilitation
01/2020
1Surgical Amputation (Amputations)
11/2017
1Heart Transplantation (Grafting, Heart)
11/2014
1Thrombolytic Therapy
10/2010
1Cardiopulmonary Bypass (Heart-Lung Bypass)
08/2005